MitoQ

Neurotech2020: It’s a brave new world

Latest articles

A better model organism for testing antiaging drugs?

Harvard researcher proposes the Daphnia water flea as an alternative to worms for building a scalable platform for antiaging drugs research. In many ponds and...

Small is mighty when it comes to mitochondria supplements

Optimise, energise, revitalise – MitoQ is on a mission to supplement your mitochondrial health. Coenzyme Q10 – or CoQ10 – is made naturally in the...

What the aging field needs

Changing the narrative – Celine Halioua reveals why the aging field needs to be taught some new tricks. Celine Halioua is the Founder and CEO...

Insilico Medicine gets $255m boost for AI-powered R&D

Insilico closes $255 million to progress into human clinical trials and develop novel targets and also announces Teva Pharm collaboration. Insilico Medicine, a company driving...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...
fundraising

Editor's picks

A better model organism for testing antiaging drugs?

Harvard researcher proposes the Daphnia water flea as an alternative to worms for building a scalable platform for antiaging drugs research. In many ponds and...

Small is mighty when it comes to mitochondria supplements

Optimise, energise, revitalise – MitoQ is on a mission to supplement your mitochondrial health. Coenzyme Q10 – or CoQ10 – is made naturally in the...

What the aging field needs

Changing the narrative – Celine Halioua reveals why the aging field needs to be taught some new tricks. Celine Halioua is the Founder and CEO...
MitoQ

Click the globe for translations.

It’s an online conference, but not as you know it. Say goodbye to Zoom fatigue and hello to Neurotech2020.

Understanding the brain, consciousness and thought processes; protect them from the ravages of aging, age-related diseases and maybe even death. We’re working with our friends at neurotech.com to assemble the finest minds to share and discuss (and brainstorm) the neurotech state of play and what’s coming next.

Longevity.Technology: When you do something that’s incredibly full-on, there’s a period afterwards when you think: “Never again!”.  However, a couple of months later you remember the buzz, the energy, how much everyone got out of it, and you have a brainwave: “Actually, that was fab … we should do it again, but switch-it-up.”

Well, with Longevity2021 firmly in next year, we are delighted to announce Neurotech2020: a series of presentations, round tables, live demos and after hours events that put neurotech front and centre. Coffee? Make mine a double … it’s running over 2 weeks (yep).

 

 

The Longevity.Technology team has joined forces with Alon Braun, a business architect, who is skilled at helping ideas grow into products, something that is vital in the Longevity and Neurotech sectors. Together with Dmitry Kaminskiy, he founded neurotech.com and Braun is clear on the importance of neurotech and its ability “to bring big money into Longevity.”

Running over a two-week period from 30 November – 11 December Neurotech2020 will take the format of online lab demos and presentations, with opportunities to network with the speakers in breakout sessions.

Dave Asprey: he’ll be there talking 40 Years of Zen

Our stellar line-up of speakers already includes Dave Asprey, Sergey Young, Max Newlon of BrainCo, and Shawn Watson of Senescence Life Sciences with more big-hitters being added all the time.

During Neurotech2020, leaders from around the world will address these key neurotech growth subjects:

Consumer tech

Consumer Tech – launching on Cyber Monday
Neuro-gaming, biohacking and new devices, wearables, surface stimulation, bio-feedback, HRV/EMG, nootropics, neurofeedback, EEG.


 

Research
Neuroimaging, treatments for Alzheimer’s and cognitive disorders, conquering paralysis, neuromodulation, neuroethics, BCI (brain computer interfaces).


 

Clinical

Clinical
Neuroceuticals, electroceuticals, GABA, dopamine, serotonin, behavioural neuropharmacology, new modalities in epilepsy, next-generation psychiatry, spinal cord stimulation.


 

Longevity

Longevity
Neurological biomarkers, cognitive assessment, overcoming the obstacles of brain-computer interfacing, diagnostic medicine, singularity, neuroprotection, ethical analysis, neuroethics and the social impact of brain machine interface, neuroprosthetics, the role of machine learning, neuroergonomics – neurotech for every day.


 

Investment

Investment
Start-up pitch events, investment sessions, surviving the times, investor panel and start ups, neurotech IPOs/success stories, industry, industry groups.


 

“As we are shaping this conference, we are looking for speakers that have interesting technologies or new visions and bringing a variety of different perspectives together,” says Braun. “Neurotech is how we change humanity, how we improve humanity. All the things that I’m seeing as we plan it out – it will blow your mind!”

Buy tickets for the conference, or apply to speak.

Phil Newman
Editor-in-Chief Phil is Editor-in-Chief Longevity.Technology and founder of First Longevity which brings together international investors and Longevity start-ups.

In his career, Phil has held c-level management positions; applying his marketing and business development expertise into these tech sectors: Longevity; IoT; AI; Medical Devices; Biopharma; 3D Manufacturing; Smartgrid and Sustainability.
MitoQ

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Spermidine: the mind-enhancing supplement

Scientists are finding that a high intake of dietary spermidine could slow down (or reverse) the brain aging process. Memory loss and slower brain function...
fundraising

Related articles

A better model organism for testing antiaging drugs?

Harvard researcher proposes the Daphnia water flea as an alternative to worms for building a scalable platform for antiaging drugs research. In many ponds and...

Insilico Medicine gets $255m boost for AI-powered R&D

Insilico closes $255 million to progress into human clinical trials and develop novel targets and also announces Teva Pharm collaboration. Insilico Medicine, a company driving...

Molecule key to functional brain rejuvenation identified

Discovery could have important implications for the health of aging brains and development of therapies for neurodegenerative diseases. Recent studies suggest that new brain cells...

Longevity focused crypto platform to launch token auction

Lead researcher behind VitaDAO’s first project reveals more about his work and why crypto provides an exciting new funding option for longevity scientists. Later this...

Brinter accelerates 3D bioprinting with €1.2m seed fund

Modular multi-material 3D bioprinting solution hopes to develop cost-effective answer to global need for kidney transplants. Turku-based bioprinting start-up Brinter has today announced the successful closure...
Supps report ad middle